研究実績

A phase ll study of new combination regimen with trastuzumab, S-1 and CDDP in HER2- positive advanced gastric cancer; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study (HERBIS-1 trial)

Keisuke Koeda, Naotoshi Sugimoto, Junji Tanaka, Masahiro Tsuda, Wataru Okamoto, Hiroyuki Okuda, Hiroshi Imamura, Jin Matsuyama, Toshio Shimokawa, Daisuke Sakai, Norimasa Fukushima, Yukinori Kurokawa, Yoshito Komatsu, Toshimasa Tsujinaka, Hiroshi Furukawa, A phase ll study of new combination regimen with trastuzumab, S-1 and CDDP in HER2- positive advanced gastric cancer; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study (HERBIS-1 trial), ASCO 2013.

前の記事 次の記事 一覧ページへ戻る